Congratulations to our longstanding client, Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on
Continue Reading Congratulations to longstanding GT Client Enlivex on Completing Multi-Million Dollar Offering

Israeli business Journal Globes recently reported 2020 to be a record-breaking year for Israeli companies raising capital on the New York and Tel Aviv Stock Exchanges.

Since the beginning of
Continue Reading Over US $8 Billion Raised by Israeli Companies in 2020 on Public Markets

GT Tel Aviv client Nym Health (“Nym”) recently announced that Geisinger is deploying the company’s autonomous medical coding technology to all nine of its hospital emergency departments. Nym, a pioneer
Continue Reading Tel Aviv Client’s Autonomous Medical Coding Technology to be Deployed by Geisinger Hospitals

As part of their free Lunch & Learn speaker series, Jewish National Fund-USA (JNF-USA) will be hosting a discussion about innovation in the realms of biotechnology, pharmaceuticals, and agricultural technology
Continue Reading Bob Grossman to Moderate JNF’s Virtual Event on US-Israeli Innovations in the Life Sciences

14756-0612-NY-gtMKG_PatentReform-3

Greenberg Traurig will be sponsoring two major Israel events this coming week.
The first is the OurCrowd Global Investor Summit (January 25-26), set to bring together 3,000 investors and companies
Continue Reading Greenberg Traurig to Sponsor Two Major Israel Event

san-francisco_image

Innovation and progress are core ingredients in today’s financial ecosystem, especially in the fields of health care and life sciences.  Greenberg Traurig has a renowned healthcare practice, serving many
Continue Reading GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco